Treace Medical Concepts (TMCI) Change in Accured Expenses (2020 - 2026)

Treace Medical Concepts (TMCI) has 7 years of Change in Accured Expenses data on file, last reported at -$3.1 million in Q1 2026.

• Quarterly Change in Accured Expenses rose 49.3% year-over-year to -$3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $627000.0 (up 108.77% YoY) and the FY2025 annual result came in at -$2.4 million, up 69.47% from the prior year.
• Change in Accured Expenses declined to -$3.1 million in Q1 2026, from $778000.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $9.5 million in Q4 2023 to a low of -$6.9 million in Q1 2024.
• A 5-year average of $71235.3 and a median of $939000.0 in 2023 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses surged 204.41% — and 2024, when it plunged 675.66%.
• Tracing TMCI's Change in Accured Expenses over 5 years: stood at $4.0 million in 2022, then surged by 136.28% to $9.5 million in 2023, then sank by 48.85% to $4.8 million in 2024, then sank by 83.96% to $778000.0 in 2025, then slumped by 501.8% to -$3.1 million in 2026.
• The last three Change in Accured Expenses figures came in at -$3.1 million (Q1 2026), $778000.0 (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.